Lexatumumab
|
WikiDoc Resources for Lexatumumab |
|
Articles |
|---|
|
Most recent articles on Lexatumumab Most cited articles on Lexatumumab |
|
Media |
|
Powerpoint slides on Lexatumumab |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Lexatumumab at Clinical Trials.gov Clinical Trials on Lexatumumab at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Lexatumumab
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Lexatumumab Discussion groups on Lexatumumab Patient Handouts on Lexatumumab Directions to Hospitals Treating Lexatumumab Risk calculators and risk factors for Lexatumumab
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Lexatumumab |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Lexatumumab (also known as ETR2-ST01) is a human monoclonal antibody used to treat cancer.